ABN Amro, Eureka Hedge Advisors to launch Asian hedge fund index

ABN Amro and Eureka Hedge Advisors, a hedge fund research and advisory service based in Hong Kong and Singapore, have launched a benchmark index for Asian hedge funds. The service is aimed at providing investors and fund managers with a means to compare the performance of hedge funds around the region.

Dubbed the ABN Amro EurekaHedge Index, it measures the performance of open-ended funds with Asian strategies and at least $40 million under management. It currently contains a sample of 51 funds with total assets under management valued at $7.8 billion. More than 75% of these are long/short equity funds, with the remainder including convertible bond arbitrage, market-neutral and multi-strategy funds.

The index is also divided geographically, with a sub-index for Asia-Pacific and another for Japan, made up of 26 Japan-only hedge funds.

"Absolute return funds measure their performance against cash, but investors still want to know how an individual fund is doing against its peer group," said John Hetherington, director of research at Eureka in Hong Kong.

The current data shows Asia's hedge funds have outperformed traditional long-only funds since late 2000, when the collection of data began. Asia-Pacific hedge funds increased 14% in value from December 2000 to April 2002, while Japanese hedge funds gained 11% in the same period. This compares with declines of 16% and 25% in the MSCI Index for Asia-Pacific and Japan, respectively, said Eureka Hedge Advisors.

Jerry Pang, a consultant at Eureka, added that $14 billion is invested in Asian strategies. He expected this figure to grow by more than 20% this year.

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here